Keywords: ipsen, operating, profit, climbs, french, drugmaker, reported
Ipsen's 2007 operating profit climbs 12%
Article | 10 March 2008
French drugmaker Ipsen has reported full-year 2007 operating profit of 208.9 million euros ($317.5 million), up 11.6% on the previous year. The firm said ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
